| Literature DB >> 35651880 |
Margot Fodor1,2, Lukas Lanser3, Julia Hofmann1,2, Giorgi Otarashvili1,2, Marlene Pühringer1,2, Benno Cardini1,2, Rupert Oberhuber1,2, Thomas Resch1,2, Annemarie Weissenbacher1,2, Manuel Maglione1, Christian Margreiter1, Philipp Zelger4, Johannes D Pallua5, Dietmar Öfner1, Robert Sucher6, Theresa Hautz1,2, Stefan Schneeberger1,2.
Abstract
Normothermic machine perfusion (NMP) allows for ex vivo viability and functional assessment prior to liver transplantation (LT). Hyperspectral imaging represents a suitable, non-invasive method to evaluate tissue morphology and organ perfusion during NMP. Liver allografts were subjected to NMP prior to LT. Serial image acquisition of oxygen saturation levels (StO2), organ hemoglobin (THI), near-infrared perfusion (NIR) and tissue water indices (TWI) through hyperspectral imaging was performed during static cold storage, at 1h, 6h, 12h and at the end of NMP. The readouts were correlated with perfusate parameters at equivalent time points. Twenty-one deceased donor livers were included in the study. Seven (33.0%) were discarded due to poor organ function during NMP. StO2 (p < 0.001), THI (p < 0.001) and NIR (p = 0.002) significantly augmented, from static cold storage (pre-NMP) to NMP end, while TWI dropped (p = 0.005) during the observational period. At 12-24h, a significantly higher hemoglobin concentration (THI) in the superficial tissue layers was seen in discarded, compared to transplanted livers (p = 0.036). Lactate values at 12h NMP correlated negatively with NIR perfusion index between 12 and 24h NMP and with the delta NIR perfusion index between 1 and 24h (rs = -0.883, p = 0.008 for both). Furthermore, NIR and TWI correlated with lactate clearance and pH. This study provides first evidence of feasibility of hyperspectral imaging as a potentially helpful contact-free organ viability assessment tool during liver NMP.Entities:
Keywords: hyperspectral; imaging; liver; machine; normothermic; perfusion; transplantation
Mesh:
Substances:
Year: 2022 PMID: 35651880 PMCID: PMC9150258 DOI: 10.3389/ti.2022.10355
Source DB: PubMed Journal: Transpl Int ISSN: 0934-0874 Impact factor: 3.842
FIGURE 1(A) Overview describing the methodology and sample collection of the study; (B) OrganOx metra® system used for normothermic machine perfusion (14, 16, 52); (C) TIVITA® Tissue System used for hyperspectral imaging (21); (D) Images acquired during liver normothermic machine perfusion: RGB image, hyperspectral images for oxygenation (StO2), perfusion (NIR perfusion), hemoglobin (THI), and water concentration (TWI), with region of interest (ROI) markers within the parenchyma of liver allografts ICV, Inferior vena cava; PV, Portal vein; HA, Hepatic artery; BD, Bile duct; StO2, Tissue Oxygen Saturation; THI, Tissue Hemoglobin Index; NIR, Near-Infrared Perfusion Index; TWI, Tissue Water Index.
Demographic data.
| Total ( | Transplanted ( | Not transplanted (n = 7) |
| |
|---|---|---|---|---|
|
| ||||
| Age (y) | 61 (48–70) | 66 (56–70) | 46 (43–56) |
|
| Gender |
| |||
| • Man | 13 (61.9) | 6 (42.9) | 7 (100) | |
| • Woman | 8 (38.1) | 8 (57.1) | ||
| BMI (kg/m2) | 26 (24–28) | 26 (24–28) | 28 (23–31) |
|
| ICU time (d) | 3 (2–7) | 4 (2–7) | 2 (2–7) |
|
| CIT (h) | 6 (5–8) | 6 (5–8) | 7 (5–9) |
|
| Cause of death |
| |||
| Cerebrovascular | 15 (71.4) | 10 (71.4) | 5 (71.4) | |
| Circulatory | 2 (9.5) | 1 (7.1) | 1 (14.3) | |
| Trauma | 1 (4.8) | 1 (14.3) | ||
| Other | 3 (14.3) | 3 (21.4) | ||
| ECD donor | 16 (76.2) | 10 (71.4) | 6 (85.7) |
|
| Donor Type |
| |||
| DBD | 15 (71.4) | 10 (71.4) | 5 (71.4) | |
| DCD | 6 (28.6) | 4 (28.6) | 2 (28.6) | |
| DRI | 2.119 (1.610–2.435) | 2.268 (1.728–2.482) | 1.760 (1.480–2.220) |
|
| Hypertension | 7 (33.3) | 4 (28.6) | 3 (42.9) |
|
| Alcohol Abuse | 4 (19) | 1 (7.1) | 3 (42.9) |
|
| Malignancy | 2 (9.5) | 1 (7.1) | 1 (14.3) |
|
| Steatosis hepatis | 11 (52.4) | 6 (42.9) | 5 (71.4) |
|
| • Mild (<40%) | 10 (47.6) | 5 (35.7) | 5 (71.4) | |
| • Moderate (40%–80%) | 1 (4.8) | 1 (7.2) | 0 (0) | |
| • Severe (>80%) | 0 (0) | 0 (0) | 0 (0) | |
| NMP indication | ||||
| • Complex recipient | 2 (9.5) | 2 (14.3) |
| |
| • Marginal donor | 18 (85.7) | 11 (78.6) | 7 (100) |
|
| • Logistics | 8 (38.1) | 6 (42.9) | 2 (28.6) |
|
| NMP time (h) | 15 (11–20) | 15 (13–20) | 12 (7–22) |
|
| Total preservation time (h) | 20 (17–27) | 21 (17–27) | 19 (9–30) |
|
|
| ||||
| Age (y) | 62 (58–65) | |||
| Gender | ||||
| • Man | 10 (71.4) | |||
| • Woman | 4 (28.6) | |||
| BMI (kg/m2) | 25.7 (21.8–28.2) | |||
| MELD | 17 (8–21) | |||
| Time on waiting list (d) | 52 (37–197) | |||
| BAR score | 7 (7–10) | |||
| BAR score ≥ 8 | 6 (42.9) | |||
| Total hospital stay (d) | 28 (21–46) | |||
| ICU stay (d) | 6 (4–18) | |||
| Early allograft dysfunction | 6 (42.9) | |||
| MEAF score | 5.67 (4.02–6.90) | |||
| L-Graft score | −0.73 (-1.33–0.07) | |||
| Clavien Dindo ≥3 | 11 (78.6) | |||
| 90—days readmission rate (unplanned) | 4 (28.6) | |||
| Biliary complications | 9 (64.3) | |||
| • ≤ 30 d | 6 (42.9) | |||
| • > 30 d | 3 (21.4) | |||
| • Biliary leakage | 4 (28.6) | |||
| • Anastomotic stricture | 4 (28.6) | |||
| • Biliary cast syndrome | 1 (7.1) | |||
| Arterial complication | 2 (14.3) | |||
| Patient survival (d) | 106 (82–163) | |||
| Graft survival (d) | 106 (82–163) | |||
| Patient death | 2 (14.3) | |||
Values in parentheses are percentages unless indicated otherwise
Chi-square for categorical variables and Mann-Whitney-U Test for continuous variables.
Values are median (i.q.r.).
BMI, body mass index; ICU, intensive care unit; CIT, cold ischemia time; ECD, extended criteria donor; DBD, donation after brain death; DCD, donation after cardiac death; DRI, donor risk index; NMP, normothermic machine perfusion; MELD, Model for End-Stage Liver Disease; BAR, balance of risk; MEAF, model of early allograft function; L-Graft, Liver Graft Assessment Following Transplantation.
FIGURE 2Dynamic changes of HSI indices over NMP time: (A) StO2; (B) THI; (C) NIR; (D) TWI; the sample size (n = 10) indicates that the Friedman test was calculated based on the ten livers perfused over 12 h and therefore, all NMP time points could be included in the statistical analysis. StO2, Tissue Oxygen Saturation; THI, Tissue Hemoglobin Index; NIR, Near-Infrared Perfusion Index; TWI, Tissue Water Index.
FIGURE 3Dynamics of HSI indices between single time points during NMP: (A) Pre-NMP to 1 h NMP; (B) 1 h NMP to 6–12 h NMP; (C) 1 h NMP to 12–24 h NMP; (D) 6–12 h NMP to 12–24 h NMP Sing-test: *p < 0.05; **p < 0.01 StO2, Tissue Oxygen Saturation; THI, Tissue Hemoglobin Index; NIR, Near-Infrared Perfusion Index; TWI, Tissue Water Index.
FIGURE 4Differences in dynamics of HSI indices between transplanted and not-transplanted liver grafts: (A) StO2; (B) THI; (C) NIR; (D) TWI Mann-Whitney-test: *p < 0.05; **p < 0.01 StO2, Tissue Oxygen Saturation; THI, Tissue Hemoglobin Index; NIR, Near-Infrared Perfusion Index; TWI, Tissue Water Index.
FIGURE 5Significant correlations of HSI indices and clinical applied perfusion parameters: (A) NIR 12–24 h NMP/pH 12–24 h NMP; (B) TWI pre-NMP/pH 6 h NMP; (C) Delta NIR 1–24 h NMP/Lactate 12 h NMP; (D) NIR 12–24 h NMP/Lactate 12 h NMP; (E) TWI 6–12 h NMP/pH 12 h NMP; (F) Delta TWI pre-NMP-1h NMP/pH 12 h NMP Spearman´s correlation: rs, Spearman’s Rank Correlation Coefficient; *p < 0.05; **p < 0.01 NIR, Near-Infrared Perfusion Index; TWI, Tissue Water Index.